[P60] Poster Session 60　Lung Cancer/Thoracic Cancer（Chemo NSCLC）

[P60-3] Phase II study of ramucirumab and docetaxel for NSCLC patients with malignant pleural effusion, an interim analysis

^○Shinnosuke Takemoto¹, Minoru Fukuda², Suyama Takayuki¹, Hiroshi Gyotoku¹, Hiroyuki Yamaguchi¹, Ryosuke Ogata³, Midori Shimada³, Hiroaki Senju³, Katsumi Nakatomi⁴, Kazutoshi Komiya⁴, Eisuke Sasaki⁴, Nanae Sugasaki⁵, Hiromi Tomono⁶, Kazumasa Akagi⁷, Sawana Ono¹, Takaya Ikeda⁸, Seiji Nagashima⁶, Hiroshi Soda³, Akitoshi Kinoshita⁵, Hiroshi Mukae¹ (1.Department of Respiratory Medicine, Nagasaki University Hospital, 2.Department of Clinical Oncology Center, Nagasaki University Hospital, 3.Department of Respiratory Medicine, Sasebo City General Hospital, 4.Department of Respiratory Medicine, National Hospital Organization Ureshino Medical Center, 5.Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, 6.Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, 7.Division of Molecular Pharmacology, National Cancer Center Research Institute, 8.Department of Respiratory Medicine, Nagasaki Kita Tokushukai Hospital)